FDA Approved: PSORCON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PSORCON (diflorasone diacetate) filed by Sun Pharmaceutical Industries, likely updating labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis
• Psoriasis

Drugs mentioned

• PSORCON (DIFLORASONE DIACETATE)

Snippet

SUPPL AP for PSORCON (DIFLORASONE DIACETATE)